ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS

• Overcoming Real-World Data Capture Challenges In Phase 4 Trials

  As the demand for real-world insights continues to grow, learn why navigating challenges and leveraging emerging opportunities becomes crucial for advancing clinical research in the real-world setting.

• Breaking Down Barriers: Why Closed Technology Ecosystems Are Holding Back Clinical Research

  Explore the barriers created by closed technology ecosystems and the importance of open, interoperable solutions for advancing healthcare.

• Five Ways Site-Facing Technology Helps Sponsors And CROs

  Site-facing technology is presented as a crucial enabler of efficient trial execution, aligning site operations with sponsor timelines and objectives.

• CRO Uses CRIO eSource To Double Monitoring Productivity

  Examine the transformative impact of eSource technology on monitoring productivity during a global Phase 3 trial conducted by a Contract Research Organization (CRO) amid the COVID-19 pandemic.

• eISF In European Clinical Trials And How eBinders Can Help

  By addressing the unique hurdles tied to regulations in European clinical trials, eBinders offer a streamlined approach to managing electronic trial documentation.

• 3-Week Database Builds That Withstood FDA Review

  Learn how a lean clinical team deployed global, regulator-ready databases in just three weeks to secure immediate Phase 3 entry and transform reproductive health research.

• Reframing Vendor Selection: Beyond Price And Past Relationships

  An RFP is more than a budget tool — it’s a strategic communication document that guides vendors, clarifies expectations, and enables informed, data-driven sponsor decisions.

• Calling All Assessment Authors: Do You Want To Share Your COA With Sponsors Across The Globe?

  Explore how eCOAs will become an effective way to capture data remotely throughout the trial as sponsors shift to decentralized clinical trials.

• Televisits In Clinical Trials: Why Integrate A Telemedicine Feature In Your eCOA Trials?

  If remote visits are planned in both decentralized and hybrid trials, how precisely do the televisits work and how beneficial can this really be to study patients, site staff, and sponsors?

• Build Or Buy: Adopting AI Agents In Life Sciences

  Should your team build custom AI agents from scratch or partner with a ready-made solution? This practical guide cuts through the hype to reveal the strategic insights you need.